Intellia Therapeutics (NasdaqGM:NTLA) FY Conference January 14, 2026 12:00 PM ET Company ParticipantsEd Dulac - CFOJohn Leonard - CEOConference Call ParticipantsNone - Analyst 1Brian Cheng - Senior Biotech AnalystNone - Analyst 2Brian ChengGood morning. Thanks for joining us for another session at the 44th JPMorgan Healthcare Conference. I'm Brian Cheng, one of the senior biotech analysts here at the firm. On stage, we have Intellia Therapeutics. I'll now pass the mic to their CEO, John Leonard, for a short ...